Adaptive Biotechnologies Corp reports results for the quarter ended in September - Earnings Summary

Adaptive Biotechnologies

03/11/2022 22:49

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a
quarterly
adjusted loss of 32 cents​​ per share for the quarter ended in
September. The mean expectation of nine analysts for the quarter
was for a loss of 38 cents per share.
    * Revenue rose 21.2% to $47.83 million from a year ago;
analysts
expected $48.03 million. 
    * Adaptive Biotechnologies Corp's reported EPS for the
quarter was
a loss of 32 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.2%
in the last three months.​ 
    * In the last 30 days three analysts negatively revised
earnings
estimates 
    * Adaptive Biotechnologies Corp shares had risen by 10.3%
this
quarter and lost 72.0% so far this year.
    * The company reported a quarterly loss of $45.28 million.
    * Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 10:49 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.38          -0.32          Beat
 Jun. 30 2022      -0.43          -0.37          Beat
 Mar. 31 2022      -0.46          -0.44          Beat
 Dec. 31 2021      -0.45          -0.43          Beat